TWLV vs. ENGN, DHHC, SBEA, NETD, ENPC, CDRO, IPXX, XPAX, KAII, and LGVC
Should you be buying Twelve Seas Investment Company II stock or one of its competitors? The main competitors of Twelve Seas Investment Company II include enGene (ENGN), DiamondHead (DHHC), SilverBox Engaged Merger Corp I (SBEA), Nabors Energy Transition Corp. II (NETD), Executive Network Partnering (ENPC), Codere Online Luxembourg (CDRO), Inflection Point Acquisition Corp. II (IPXX), Zalatoris II Acquisition (XPAX), Kismet Acquisition Two (KAII), and LAMF Global Ventures Corp. I (LGVC).
enGene (NASDAQ:ENGN) and Twelve Seas Investment Company II (NASDAQ:TWLV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.
enGene received 7 more outperform votes than Twelve Seas Investment Company II when rated by MarketBeat users.
64.2% of enGene shares are held by institutional investors. Comparatively, 7.9% of Twelve Seas Investment Company II shares are held by institutional investors. 13.7% of enGene shares are held by company insiders. Comparatively, 79.8% of Twelve Seas Investment Company II shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
enGene presently has a consensus target price of $34.40, suggesting a potential upside of 181.28%. Given Twelve Seas Investment Company II's higher probable upside, equities research analysts clearly believe enGene is more favorable than Twelve Seas Investment Company II.
enGene has a beta of -0.4, suggesting that its stock price is 140% less volatile than the S&P 500. Comparatively, Twelve Seas Investment Company II has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500.
In the previous week, enGene had 37 more articles in the media than Twelve Seas Investment Company II. MarketBeat recorded 39 mentions for enGene and 2 mentions for Twelve Seas Investment Company II. enGene's average media sentiment score of 1.89 beat Twelve Seas Investment Company II's score of 0.05 indicating that Twelve Seas Investment Company II is being referred to more favorably in the news media.
Twelve Seas Investment Company II's return on equity of 0.00% beat enGene's return on equity.
Summary
enGene beats Twelve Seas Investment Company II on 6 of the 11 factors compared between the two stocks.
Get Twelve Seas Investment Company II News Delivered to You Automatically
Sign up to receive the latest news and ratings for TWLV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TWLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Twelve Seas Investment Company II Competitors List
Related Companies and Tools
